These and other GLP1-RA diabetes/weight-loss meds can also boost outcomes for folks battling chronic kidney disease, new ...

A latest research led by Dr Shuyao Zhang, an assistant professor of internal medicine at UT Southwestern in Dallas reveal the ...

Kidney disease, leading to kidney failure, afflicts disproportionately more black people than white people. Thus, there is a ...

Learn how chronic kidney disease and diabetes accelerate heart risk, with new research revealing early warning signs.

Duncan, who has chronic kidney disease, has worked with dance companies in Chicago and around the world over his decades-long ...

Chronic health conditions are having a serious, negative impact on the welfare of the country's workers and their output, a ...

Chronic kidney disease (CKD) is a progressive renal disease that causes kidney function to deteriorate. It appears as urinary ...

Over 1,000 genes may serve as possible treatment targets for individuals with kidney disease, according to a new study. By creating the most complete and detailed genetic 'map' of kidney function to ...

The Food and Drug Administration approved Novo Nordisk’s Ozempic as the first GLP-1 treatment option for people with type 2 ...

Like most people who have been diagnosed with a life-threatening disease, Ruel Bautista is still trying to come to terms with ...

The FDA has approved Ozempic (semaglutide) to reduce the risk of kidney disease worsening and cardiovascular death in those with T2D and CKD.

Dialysis Centers used data from the Centers for Disease Control and Prevention to examine the prevalence of chronic diseases ...